Watson Pharmaceuticals, Inc. (WPI) Tops Q1 EPS by 4c; Guides FY12 Sales
Tweet
Share
E-mailGet Alerts WPI Hot Sheet
Price: $85.73 --0%
Financial Fact:
Income before income taxes and noncontrolling interests: 96.9M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Financial Fact:
Income before income taxes and noncontrolling interests: 96.9M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Watson Pharmaceuticals, Inc. (NYSE: WPI) reported Q1 EPS of $1.64, $0.04 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.52 million versus the consensus estimate of $1.48 million.
Sees FY12 sales of $5.5 billion, versus the consensus of $5.5 billion.
For earnings history and earnings-related data on Watson Pharmaceuticals, Inc. (WPI) click here.
Sees FY12 sales of $5.5 billion, versus the consensus of $5.5 billion.
For earnings history and earnings-related data on Watson Pharmaceuticals, Inc. (WPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- GitLab’s second-quarter revenue jumps 21% as AI demand drives bookings
- Stifel Starts Taiwan Semi (TSM) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
